Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells
Claire Gourzonès(Centre National de la Recherche Scientifique), Jérôme Moreaux(Centre National de la Recherche Scientifique)
Cited by 30
Related Papers
Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells
|Virology Journal|2010|124
PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs
|Clinical Epigenetics|2018|47
Identification of a 20-Gene Expression-Based Risk Score as a Predictor of Clinical Outcome in Chronic Lymphocytic Leukemia Patients
|BioMed Research International|2014|20
Transient loss of Polycomb components induces an epigenetic cancer fate
|bioRxiv (Cold Spring Harbor Laboratory)|2023|12